167 related articles for article (PubMed ID: 22146051)
1. The crystal structure of protease Sapp1p from Candida parapsilosis in complex with the HIV protease inhibitor ritonavir.
Dostál J; Brynda J; Hrušková-Heidingsfeldová O; Pachl P; Pichová I; Rezáčová P
J Enzyme Inhib Med Chem; 2012 Feb; 27(1):160-5. PubMed ID: 22146051
[TBL] [Abstract][Full Text] [Related]
2. Structure-based specificity mapping of secreted aspartic proteases of Candida parapsilosis, Candida albicans, and Candida tropicalis using peptidomimetic inhibitors and homology modeling.
Majer F; Pavlícková L; Majer P; Hradilek M; Dolejsí E; Hrusková-Heidingsfeldová O; Pichová I
Biol Chem; 2006 Sep; 387(9):1247-54. PubMed ID: 16972793
[TBL] [Abstract][Full Text] [Related]
3. The crystal structure of the secreted aspartic protease 1 from Candida parapsilosis in complex with pepstatin A.
Dostál J; Brynda J; Hrusková-Heidingsfeldová O; Sieglová I; Pichová I; Rezácová P
J Struct Biol; 2009 Aug; 167(2):145-52. PubMed ID: 19401235
[TBL] [Abstract][Full Text] [Related]
4. Insight into the structural similarity between HIV protease and secreted aspartic protease-2 and binding mode analysis of HIV-Candida albicans inhibitors.
Calugi C; Guarna A; Trabocchi A
J Enzyme Inhib Med Chem; 2013 Oct; 28(5):936-43. PubMed ID: 22803674
[TBL] [Abstract][Full Text] [Related]
5. Structural determinants for subnanomolar inhibition of the secreted aspartic protease Sapp1p from
Dostál J; Brynda J; Vaňková L; Zia SR; Pichová I; Heidingsfeld O; Lepšík M
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):914-921. PubMed ID: 33843395
[TBL] [Abstract][Full Text] [Related]
6. Atomic resolution crystal structure of Sapp2p, a secreted aspartic protease from Candida parapsilosis.
Dostál J; Pecina A; Hrušková-Heidingsfeldová O; Marečková L; Pichová I; Řezáčová P; Lepšík M; Brynda J
Acta Crystallogr D Biol Crystallogr; 2015 Dec; 71(Pt 12):2494-504. PubMed ID: 26627656
[TBL] [Abstract][Full Text] [Related]
7. Biosensor-based screening and characterization of HIV-1 inhibitor interactions with Sap 1, Sap 2, and Sap 3 from Candida albicans.
Backman D; Monod M; Danielson UH
J Biomol Screen; 2006 Mar; 11(2):165-75. PubMed ID: 16418316
[TBL] [Abstract][Full Text] [Related]
8. Exposure to therapeutic concentrations of ritonavir, but not saquinavir, reduces secreted aspartyl proteinase of Candida parapsilosis.
Asencio MA; Garduño E; Pérez-Giraldo C; Blanco MT; Hurtado C; Gómez-García AC
Chemotherapy; 2005 Aug; 51(5):252-5. PubMed ID: 16088122
[TBL] [Abstract][Full Text] [Related]
9. Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitors.
Gruber A; Berlit J; Speth C; Lass-Flörl C; Kofler G; Nagl M; Borg-von Zepelin M; Dierich MP; Würzner R
Immunobiology; 1999 Sep; 201(1):133-44. PubMed ID: 10532286
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for HTLV-1 protease inhibition by the HIV-1 protease inhibitor indinavir.
Kuhnert M; Steuber H; Diederich WE
J Med Chem; 2014 Jul; 57(14):6266-72. PubMed ID: 25006983
[TBL] [Abstract][Full Text] [Related]
11. Insights into the mechanism of drug resistance: X-ray structure analysis of multi-drug resistant HIV-1 protease ritonavir complex.
Liu Z; Yedidi RS; Wang Y; Dewdney TG; Reiter SJ; Brunzelle JS; Kovari IA; Kovari LC
Biochem Biophys Res Commun; 2013 Feb; 431(2):232-8. PubMed ID: 23313846
[TBL] [Abstract][Full Text] [Related]
12. Secreted aspartic proteases of Candida albicans, Candida tropicalis, Candida parapsilosis and Candida lusitaniae. Inhibition with peptidomimetic inhibitors.
Pichová I; Pavlícková L; Dostál J; Dolejsí E; Hrusková-Heidingsfeldová O; Weber J; Ruml T; Soucek M
Eur J Biochem; 2001 May; 268(9):2669-77. PubMed ID: 11322888
[TBL] [Abstract][Full Text] [Related]
13. The inhibition of Candida-albicans-secreted aspartic proteases by three different HIV protease inhibitors.
Monod M; Borg-von Zepelin M; Telenti A; Sanglard D
Dermatology; 1999; 198(4):412-4. PubMed ID: 10490300
[No Abstract] [Full Text] [Related]
14. Oropharyngeal candidiasis in HIV-infected patients under treatment with protease inhibitors.
Migliorati CA; Birman EG; Cury AE
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Sep; 98(3):301-10. PubMed ID: 15356467
[TBL] [Abstract][Full Text] [Related]
15. HIV-Protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases.
Borg-von Zepelin M; Meyer I; Thomssen R; Würzner R; Sanglard D; Telenti A; Monod M
J Invest Dermatol; 1999 Nov; 113(5):747-51. PubMed ID: 10571729
[TBL] [Abstract][Full Text] [Related]
16. HIV protease inhibitors attenuate adherence of Candida albicans to epithelial cells in vitro.
Bektić J; Lell CP; Fuchs A; Stoiber H; Speth C; Lass-Flörl C; Borg-von Zepelin M; Dierich MP; Würzner R
FEMS Immunol Med Microbiol; 2001 Jul; 31(1):65-71. PubMed ID: 11476984
[TBL] [Abstract][Full Text] [Related]
17. The precursor of secreted aspartic proteinase Sapp1p from Candida parapsilosis can be activated both autocatalytically and by a membrane-bound processing proteinase.
Dostál J; Dlouhá H; Malon P; Pichová I; Hrusková-Heidingsfeldová O
Biol Chem; 2005 Aug; 386(8):791-9. PubMed ID: 16201875
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, inhibition studies, and molecular modeling of pepstatin analogues addressing different secreted aspartic proteinases of Candida albicans.
Cadicamo CD; Mortier J; Wolber G; Hell M; Heinrich IE; Michel D; Semlin L; Berger U; Korting HC; Höltje HD; Koksch B; Borelli C
Biochem Pharmacol; 2013 Apr; 85(7):881-7. PubMed ID: 23262278
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of aspartic proteinase from Irpex lacteus in complex with inhibitor pepstatin.
Fujimoto Z; Fujii Y; Kaneko S; Kobayashi H; Mizuno H
J Mol Biol; 2004 Aug; 341(5):1227-35. PubMed ID: 15321718
[TBL] [Abstract][Full Text] [Related]
20. Potent HIV protease inhibitors containing a novel (hydroxyethyl)amide isostere.
Beaulieu PL; Wernic D; Abraham A; Anderson PC; Bogri T; Bousquet Y; Croteau G; Guse I; Lamarre D; Liard F; Paris W; Thibeault D; Pav S; Tong L
J Med Chem; 1997 Jul; 40(14):2164-76. PubMed ID: 9216835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
